NFKB1 and RSF1

  • Number of citations of the paper that reports this interaction (PMID 15242768)
  • 6
  • Data Source:
  • HPRD (in vitro, in vivo)

NFKB1

RSF1

Gene Name nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 remodeling and spacing factor 1
Image No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 102 interactors: ABCC2 AR ATF3 BCL3 BRCA1 BTRC CDK9 CEBPB CFLAR CHUK COPB2 COPS5 CTNNB1 E2F1 ECSIT ELF1 ELF3 EP300 ESR1 ETS1 FBXW11 FOS G3BP2 GLUL GSK3B HDAC1 HIF1AN HMGA1 HMGA2 HMGB1 HSPA4 IKBKB IKBKG IL2RA IRF1 IRF2 IRF8 IRF9 ITGB3BP KAT5 KLF5 KPNA3 LYL1 MAP3K8 MEN1 MPP6 MTPN NCOA1 NCOA6 NCOR2 NFKB2 NFKBIA NFKBIB NFKBIE NFKBIZ NFRKB NKRF NOTCH1 NR3C1 NR4A1 PARP1 PCBD1 PDCD11 PELP1 PLD3 PML PPARG PPP4C PRKACA PSMD10 REL RELA RELB RGS14 RIPK1 RPS3 RSF1 RXRA SERPINA3 SF1 SIN3A SP1 SPAG9 SPI1 SPPL2A SRF STAT3 STAT6 TAB2 TNFSF11 TNIP1 TNIP2 TP53BP1 TRIP4 TSC22D3 TXN UBE2D3 UBE2K UNC5CL YWHAQ YY1 ZBTB9 3 interactors: CSNK2A1 NFKB1 SMARCA5
Entrez ID 4790 51773
HPRD ID 01238 10537
Ensembl ID ENSG00000109320 ENSG00000048649
Uniprot IDs P19838 Q05DG0 Q96T23
PDB IDs 1MDI 1MDJ 1MDK 1NFI 1SVC 2DBF 2O61 3GUT
Enriched GO Terms of Interacting Partners?
Tagcloud ?
30min  ancestry  asks  asleep  habitual  ifng  ifngr1  il10  il13  il17a  il1b  il1r2  il2  il4  il6  il8  interleukins  nfkb2  pittsburgh  rs1143623  rs1143642  rs1295686  rs2857602  rs4648110  rs4719714  soi  strengthens  tnfa  transgender 
11q  adjusting  adjuvant  amplification  amplified  benefit  besides  biomarkers  ccnd1  clinico  copy  estrogen  estrogens  ma  measure  node  obtain  os  pathologic  placebo  predictive  preferentially  premenopausal  rfs  select  spacing  tamoxifen  unlike  yrs 
Tagcloud (Difference) ?
30min  ancestry  asks  asleep  habitual  ifng  ifngr1  il10  il13  il17a  il1b  il1r2  il2  il4  il6  il8  interleukins  nfkb2  pittsburgh  rs1143623  rs1143642  rs1295686  rs2857602  rs4648110  rs4719714  soi  strengthens  tnfa  transgender 
11q  adjusting  adjuvant  amplification  amplified  benefit  besides  biomarkers  ccnd1  clinico  copy  estrogen  estrogens  ma  measure  node  obtain  os  pathologic  placebo  predictive  preferentially  premenopausal  rfs  select  spacing  tamoxifen  unlike  yrs 
Tagcloud (Intersection) ?